Medicare still won't cover hearing aids in 2026, but the OTC market is becoming a stronger alternative
For most of the history of hearing aids, cost was the conversation stopper. Prescription devices averaged $2,694 a pair in 2026 and Original Medicare still doesn’t cover them. The FDA’s 2022 ruling creating the OTC hearing aid category was designed specifically to break that logjam, and three years in the market has finally caught up with the promise. Here’s what actually matters when you’re deciding whether to buy and what to buy.
Medicare and Hearing Aid Coverage Reality in 2026
Start here because it shapes every other decision. Original Medicare Part A and Part B exclude hearing aids entirely in 2026, though some Medicare Advantage plans offer a limited hearing benefit worth checking before purchasing. The Medicare Hearing Aid Coverage Act of 2025 was introduced to add hearing aids to Part B starting January 1, 2026, but had not been enacted as of mid-2026. For most people, OTC is the most realistic path to affordable treatment right now.
What OTC Hearing Aids Are and What They Can Do
The FDA created the OTC category in October 2022 for adults 18 and older with self-perceived mild to moderate hearing loss. No prescription, audiologist visit or professional fitting required.
By 2026 the best OTC models have closed the performance gap with prescription devices significantly, matching them on AI processing, Bluetooth streaming, app control and water resistance for mild to moderate hearing loss, according to independent lab testing.
They’re not appropriate for children, adults with severe or profound hearing loss or anyone with complex audiological needs. One category distinction worth making clearly: Personal Sound Amplification Products, or PSAPs, are consumer electronics for people without hearing loss. They’re not regulated as medical devices and aren’t a substitute for an OTC hearing aid.
How to Know If You Need OTC Hearing Aids
The most common signs of mild to moderate hearing loss include asking people to repeat themselves regularly, difficulty following conversations in restaurants or noisy settings, trouble on phone calls and turning the TV louder than others prefer. Fatigue from straining to hear throughout the day is another signal that often goes unrecognized.
Some symptoms require a medical evaluation before any device purchase. See a clinician rather than reaching for a hearing aid if you have fluid, pus or blood from the ear within the past six months, ear pain or discomfort, vertigo paired with hearing changes, sudden or rapidly worsening hearing loss within 90 days, or hearing that has fluctuated between worse and better within six months. Those symptoms can point to treatable causes no hearing aid will fix.
What to Look for When Shopping For OTC Hearing Aids
Self-fitting vs. preset. Self-fitting OTC aids go through FDA clearance for safety, usability and effectiveness before hitting shelves. Preset models don’t carry that same requirement, making quality more variable, especially at lower price points. Audiologists generally recommend self-fitting when the budget allows.
Speech-in-noise performance. The single most important real-world differentiator, and the hardest to assess from marketing language. Lean on independent lab scores rather than brand claims.
Battery and connectivity. Rechargeable models lasting 20 to 30 hours per charge are standard in 2026. Bluetooth streaming to both iPhone and Android and app-based tuning are now baseline features, not premium extras.
Trial period. Most reputable brands offer 30 to 45 days risk-free. Contact customer support early in the trial to test how responsive the company is before you’re committed.
Best OTC Hearing Aids for Different Budgets and Needs
Rather than a straight ranked list, here’s how the top performers break down by use case.
Best for first-time buyers on a budget: The MDHearing NEO XS starts at $297 and offers strong feedback cancellation, noise reduction and a 45-day trial. It’s the lowest-cost entry point from a brand with consistent audiologist-reviewed marks.
Best mid-range performance: The Elehear Beyond Pro at $599 is HearingTracker’s top-rated OTC device overall, ranking in the top six of all hearing aids tested including prescription models. The Yeasound RIC800 at $699 scored in the top 5% of OTC devices in independent HearAdvisor Lab testing.
Best for all-day wearers: The Jabra Enhance Select 500 runs 24 hours on a single charge and gets another 12 from one hour in the case, making it Reviewed.com’s top pick for people who need consistent, uninterrupted wear.
Best premium option with professional support: The Jabra Enhance Select 700 starts at $1,195 and pairs strong sound quality with remote audiologist support, the closest OTC experience to a prescription fitting without the clinic visit.
Best lab-verified sound clarity: The Sony CRE-E10 scored 73 out of 100 for sound clarity and 76 out of 100 for speech in loud environments in Forbes Health lab testing.
The Real Cost of Waiting
Only one in four adults who could benefit from a hearing aid has ever used one, and the average person waits nine years after a diagnosis before doing anything about it. Untreated hearing loss is tied to depression, social isolation, higher dementia risk and increased fall risk. The OTC category exists precisely to lower the barrier between recognizing a problem and actually addressing it, and in 2026 the devices have finally caught up to that promise.
This article was created by content specialists using various tools, including AI.
